M&A

Amgen hunts for deals of all sizes to combat forthcoming sales decline
Fierce Pharma
Tue, 01/29/19 - 11:17 pm
Amgen
earnings
M&A
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
Sun, 01/27/19 - 07:09 pm
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Last week in biopharma-earnings reports, drug pricing, a new GENE CEO and more
Mon, 02/4/19 - 02:45 pm
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Bristol-Myers Squibb's Q4 Earnings Update Shows Why It Needs Celgene
Motley Fool
Sun, 01/27/19 - 12:03 pm
Bristol-Myers Squibb
earnings
M&A
Celgene
What Should Digital Health Learn From Propeller Health's $225 Million Acquisition
Forbes
Sun, 01/27/19 - 11:59 am
ResMed
Propeller Health
M&A
Medtronic to acquire cardiac ablation tech dev Epix Therapeutics
Mass Device
Fri, 01/25/19 - 10:18 am
Medtronic
Epix Therapeutics
Advanced Cardiac Therapeutics
devices
M&A
Has Abbott's Acquisitive Miles White Made His Last Big Deal?
Forbes
Wed, 01/23/19 - 07:56 pm
Abbott Labs
Pharma CEOs
Miles White
M&A
J&J may nab surgical robotics company Auris Health
Mass Device
Wed, 01/23/19 - 07:46 pm
devices
M&A
JNJ
Auris Health
robotic surgery
GSK closes acquisition of Tesaro for $5.1bn
Pharmaceutical Business Review
Wed, 01/23/19 - 10:39 am
GSK
Tesaro
M&A
oncology
A flashy 2019 start to pharma M&A, but will it last?
Biopharma Dive
Tue, 01/22/19 - 11:55 pm
M&A
Celgene
Bristol-Myers Squibb
Eli Lilly
Loxo Oncology
Roche says 'no thanks' to megadeals, but don't count out smaller M&A
Fierce Pharma
Tue, 01/22/19 - 11:50 am
Roche
M&A
Christoph Franz
Takeda mulling sale of emerging market drugs – report
Pharmaforum
Tue, 01/22/19 - 11:39 am
Takeda
Shire
M&A
emerging markets
Celgene, sold for $74 billion, leaves a legacy of chutzpah in science and drug pricing
Stat
Tue, 01/22/19 - 11:38 am
Celgene
drug pricing
M&A
Bristol-Myers Squibb
Would Pfizer Shareholders Win With an Acquisition of Amarin?
Motley Fool
Sun, 01/20/19 - 03:26 pm
Pfizer
Amarin
M&A
No bidding war for Loxo, so did Lilly overpay? Don’t rush to judgment, analysts say
Fierce Pharma
Fri, 01/18/19 - 10:27 am
Eli Lilly
Loxo Oncology
M&A
Looking to make a splash at JPMorgan, Eli Lilly rushed to put its $8B buyout deal together for Loxo in 10 days
Endpoints
Thu, 01/17/19 - 11:10 am
Eli Lilly
Loxo Oncology
M&A
JPMHC 2019
Abbott to acquire mitral valve device maker Cephea Valve Tech
Mass Device
Wed, 01/16/19 - 12:02 pm
devices
Abbott Labs
mitral valve
Cephea Valve Technologies
M&A
Why Yet Another Biotech Stock Is Grabbing Renewed Takeover Chatter
Investors Business Daily
Wed, 01/16/19 - 11:55 am
Incyte
M&A
Smaller groups await Bristol-Myers Squelgene fallout
EP Vantage
Wed, 01/16/19 - 11:53 am
M&A
Bristol-Myers Squibb
Celgene
Vividion Therapeutics
Evotec
Prothena
Anokion
Skyhawk Therapeutics
Dragonfly Therapeutics
BeiGene
Agios Pharmaceuticals
Jounce Therapeutics
Congressmen to regulators: BMS-Celgene merger will stifle competition and raise drug prices
Fierce Pharma
Tue, 01/15/19 - 11:25 am
US Congress
M&A
Bristol-Myers Squibb
Celgene
drug pricing

Pages